Skip to main content
Erschienen in: World Journal of Surgery 4/2020

01.04.2020 | Original Scientific Report

Relationship Between the Waiting Times for Surgery and Survival in Patients with Gastric Cancer

verfasst von: Yuta Kumazu, Koji Oba, Tsutomu Hayashi, Takanobu Yamada, Kentaro Hara, Hiroaki Osakabe, Yota Shimoda, Masato Nakazono, Shinsuke Nagasawa, Yasushi Rino, Munetaka Masuda, Takashi Ogata, Takaki Yoshikawa, Takashi Oshima

Erschienen in: World Journal of Surgery | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Surgery for gastric cancer should be performed as soon as possible after diagnosis. However, sometimes the waiting time for surgery tends to be longer. The relation between the waiting time for surgery and survival in patients with gastric cancer remains to be fully investigated.

Methods

This retrospective, single-center cohort study evaluated patients with gastric cancer who underwent curative surgery from 2006 through 2012 at Kanagawa Cancer Center in Japan. Patients who received neoadjuvant chemotherapy were excluded. The waiting time for surgery was defined as the time between the first visit and surgery. We investigated whether the waiting time for surgery has a linear negative impact on outcomes by using a Cox regression model with clinical prognostic factors.

Results

In total, 801 patients were eligible. The median waiting time was 45 days (range 10–269 days). The restricted cubic spline regression curve showed that the adjusted time-specific hazard ratios of waiting times did not indicate a linear negative trend on survival between 20 and 100 days (p = 0.759). In the Cox model with a quartile of waiting times, waiting times in the 32–44-day group, 43–62-day group, and ≥63 day groups were not associated with poorer overall survival as compared with the ≤31 day group (HR: 1.01, 95% CI 0.63–1.60, p = 0.984, HR: 1.17, 95% CI 0.70–1.94, p = 0.550, HR: 1.06, 95% CI 0.60–1.88, p = 0.831, respectively).

Conclusions

There was no negative relation between the waiting time for surgery (within 100 days) and survival in patients with gastric cancer.
Literatur
1.
Zurück zum Zitat Observatory TGC Cancer Today, World Health Organization (2019) Observatory TGC Cancer Today, World Health Organization (2019)
2.
Zurück zum Zitat Association. JGc (2011) Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 14:113–123CrossRef Association. JGc (2011) Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 14:113–123CrossRef
3.
Zurück zum Zitat Health Do Cancer Reform Strategy, UK, Department of Health, 2007 Health Do Cancer Reform Strategy, UK, Department of Health, 2007
4.
Zurück zum Zitat Brenkman HJF, Visser E, van Rossum PSN et al (2017) Association between waiting time from diagnosis to treatment and survival in patients with curable gastric cancer: a population-based study in the Netherlands. Ann Surg Oncol 24:1761–1769CrossRef Brenkman HJF, Visser E, van Rossum PSN et al (2017) Association between waiting time from diagnosis to treatment and survival in patients with curable gastric cancer: a population-based study in the Netherlands. Ann Surg Oncol 24:1761–1769CrossRef
5.
Zurück zum Zitat Ontario CC Target Wait Times for Cancer Surgery in Ontario, 2006 Ontario CC Target Wait Times for Cancer Surgery in Ontario, 2006
6.
Zurück zum Zitat Sobin LHWC, Gospodarowicz M (2009) TNM classification of malignant tumors (UICC), 7th edn. Wiley, New York Sobin LHWC, Gospodarowicz M (2009) TNM classification of malignant tumors (UICC), 7th edn. Wiley, New York
7.
Zurück zum Zitat Nakajima T (2002) Gastric cancer treatment guidelines in Japan. Gastric Cancer 5:1–5CrossRef Nakajima T (2002) Gastric cancer treatment guidelines in Japan. Gastric Cancer 5:1–5CrossRef
8.
Zurück zum Zitat Bleicher RJ, Ruth K, Sigurdson ER et al (2016) Time to surgery and breast cancer survival in the United States. JAMA Oncol 2:330–339CrossRef Bleicher RJ, Ruth K, Sigurdson ER et al (2016) Time to surgery and breast cancer survival in the United States. JAMA Oncol 2:330–339CrossRef
9.
Zurück zum Zitat Coughlin S, Plourde M, Guidolin K et al (2015) Is it safe to wait? The effect of surgical wait time on survival in patients with non-small cell lung cancer. Can J Surg 58:414–418CrossRef Coughlin S, Plourde M, Guidolin K et al (2015) Is it safe to wait? The effect of surgical wait time on survival in patients with non-small cell lung cancer. Can J Surg 58:414–418CrossRef
10.
Zurück zum Zitat Elit LM, O’Leary EM, Pond GR et al (2014) Impact of wait times on survival for women with uterine cancer. J Clin Oncol 32:27–33CrossRef Elit LM, O’Leary EM, Pond GR et al (2014) Impact of wait times on survival for women with uterine cancer. J Clin Oncol 32:27–33CrossRef
11.
Zurück zum Zitat Flemming JA, Nanji S, Wei X et al (2017) Association between the time to surgery and survival among patients with colon cancer: a population-based study. Eur J Surg Oncol 43:1447–1455CrossRef Flemming JA, Nanji S, Wei X et al (2017) Association between the time to surgery and survival among patients with colon cancer: a population-based study. Eur J Surg Oncol 43:1447–1455CrossRef
12.
Zurück zum Zitat van Harten MC, Hoebers FJ, Kross KW et al (2015) Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral Oncol 51:272–278CrossRef van Harten MC, Hoebers FJ, Kross KW et al (2015) Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral Oncol 51:272–278CrossRef
13.
Zurück zum Zitat Visser E, Leeftink AG, van Rossum PS et al (2016) Waiting time from diagnosis to treatment has no impact on survival in patients with esophageal cancer. Ann Surg Oncol 23:2679–2689CrossRef Visser E, Leeftink AG, van Rossum PS et al (2016) Waiting time from diagnosis to treatment has no impact on survival in patients with esophageal cancer. Ann Surg Oncol 23:2679–2689CrossRef
14.
Zurück zum Zitat Neal RD, Tharmanathan P, France B et al (2015) Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer 112(Suppl 1):S92–107CrossRef Neal RD, Tharmanathan P, France B et al (2015) Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer 112(Suppl 1):S92–107CrossRef
15.
Zurück zum Zitat Yun YH, Kim YA, Min YH et al (2012) The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol 23:2731–2737CrossRef Yun YH, Kim YA, Min YH et al (2012) The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol 23:2731–2737CrossRef
16.
Zurück zum Zitat Tsukuma H, Oshima A, Narahara H et al (2000) Natural history of early gastric cancer: a non-concurrent, long term, follow up study. Gut 47:618–621CrossRef Tsukuma H, Oshima A, Narahara H et al (2000) Natural history of early gastric cancer: a non-concurrent, long term, follow up study. Gut 47:618–621CrossRef
Metadaten
Titel
Relationship Between the Waiting Times for Surgery and Survival in Patients with Gastric Cancer
verfasst von
Yuta Kumazu
Koji Oba
Tsutomu Hayashi
Takanobu Yamada
Kentaro Hara
Hiroaki Osakabe
Yota Shimoda
Masato Nakazono
Shinsuke Nagasawa
Yasushi Rino
Munetaka Masuda
Takashi Ogata
Takaki Yoshikawa
Takashi Oshima
Publikationsdatum
01.04.2020
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 4/2020
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-020-05367-8

Weitere Artikel der Ausgabe 4/2020

World Journal of Surgery 4/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.